semaglutide vs tirzepatide dose comparison dosage chart: complete side-by-side Peptides for Weight Loss: What

43 However, more patients in the liraglutide than placebo group experienced serious cardiac adverse events, including significant arrhythmia

Patients who should not use this medication include those with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) History of serious or recurring pancreatitis Known allergy to tirzepatide or any component of the injection Active gallbladder disease discuss with your provider Pregnancy or planned pregnancy discuss safer alternatives with your provider Not sure if you qualify

The search was initially conducted between July and September 2025 for the original manuscript submission and was subsequently updated during manuscript revision in March 2026 to include additional relevant studies published up to November 2025

Approximately 15% of patients taking semaglutide experienced heartburn as a side effect, highlighting it as a relatively common gastrointestinal reaction

Food and Drug Administration (FDA) in 2022 for the treatment of type 2 diabetes